Likarda, Inc. is a leading biotech company based in Kansas City, MO, specializing in the development of innovative technologies for the delivery of cell therapies, large molecules, and traditional drugs. Their Core-Shell Spherification (CSS) technology platform enhances therapeutic efficacy and provides sustainable solutions for chronic or life-threatening diseases.
At the forefront of Likarda's innovation is the CSS technology, which coats cells and biologics with inert materials to ensure they remain at their intended location within the body, shielded from rejection, and releasing therapeutic payloads in a customized manner. This technology also protects cells during freezing and thawing, optimizing their functionality for patient administration.
Generated from the website